Proteus Int PLC - Doc reMerger with Therapeutic
August 20 1999 - 9:16AM
UK Regulatory
RNS No 3029e
PROTEUS INTERNATIONAL PLC
Document Re Proposed Merger
Proposed Merger with Therapeutic Antibodies Inc and Placing
0f 23,325,000 New Ordinary Shares at 40p per share by WestLB Panmure
Sponsored by Deloitte & Touche Corporate Finance
Proposal to rename the Company Protherics PLC on Completion of the
Merger
A copy of the above is available for inspection from the Company
Announcements office of the Stock Exchange, London.
END
DOCALLVITIIIFAA
Becket Invest (LSE:TAB)
Historical Stock Chart
From Jan 2025 to Feb 2025
Becket Invest (LSE:TAB)
Historical Stock Chart
From Feb 2024 to Feb 2025